These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Effect of 1 alpha-hydroxyvitamin D3 on serum levels of thyroid hormones in hyperthyroid patients with untreated Graves' disease. Kawakami-Tani T; Fukawa E; Tanaka H; Abe Y; Makino I Metabolism; 1997 Oct; 46(10):1184-8. PubMed ID: 9322804 [TBL] [Abstract][Full Text] [Related]
43. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor. Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288 [TBL] [Abstract][Full Text] [Related]
44. The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism. Gerstein HC; Rastogi B; Iwatani Y; Iitaka M; Row VV; Volpé R Clin Invest Med; 1987 Jul; 10(4):337-44. PubMed ID: 2888555 [TBL] [Abstract][Full Text] [Related]
45. [Studies on the suppressor T cell function in patients with autoimmune thyroid diseases]. Matsui J Nihon Naibunpi Gakkai Zasshi; 1984 Aug; 60(8):925-38. PubMed ID: 6096180 [TBL] [Abstract][Full Text] [Related]
46. Development of Graves' disease from asymptomatic autoimmune thyroiditis: a case report. Kasuga Y; Kobayashi S; Fujimori M; Shingu K; Hama Y; Maruyama M; Amano J Endocr J; 1996 Dec; 43(6):743-6. PubMed ID: 9075617 [TBL] [Abstract][Full Text] [Related]
47. Detection and properties of TSH-binding inhibitor immunoglobulins in patients with Graves' disease and Hashimoto's thyroiditis. Endo K; Kasagi K; Konishi J; Ikekubo K; Okuno T; Takeda Y; Mori T; Torizuka K J Clin Endocrinol Metab; 1978 May; 46(5):734-9. PubMed ID: 45421 [TBL] [Abstract][Full Text] [Related]
48. Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease. Tötterman TH; Karlsson FA; Bengtsson M; Mendel-Hartvig I N Engl J Med; 1987 Jan; 316(1):15-22. PubMed ID: 2946953 [TBL] [Abstract][Full Text] [Related]
49. Immunomodulation by methimazole therapy in Graves' disease: rapid changes in activation stage of circulating regulatory T cell subsets, B cells and NK cells. Karlsson FA; Tötterman TH Clin Exp Immunol; 1988 Nov; 74(2):258-63. PubMed ID: 2906281 [TBL] [Abstract][Full Text] [Related]
50. Thyroid autoantigen-induced lymphocyte proliferation in Graves' disease and Hashimoto's thyroiditis. Weetman AP; Gunn C; Hall R; McGregor AM J Clin Lab Immunol; 1985 May; 17(1):1-6. PubMed ID: 3876444 [TBL] [Abstract][Full Text] [Related]
51. [Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves' disease during long-term treatment period]. Komaki T; Sakata S; Nakamura S; Matsuda M; Kojima N; Takuno H; Miura K Nihon Naibunpi Gakkai Zasshi; 1989 Jul; 65(7):627-39. PubMed ID: 2583311 [TBL] [Abstract][Full Text] [Related]
52. Evaluating the role of Th0 and Th1 clones in autoimmune thyroid disease by use of Hu-SCID chimeras. Fisfalen ME; Soltani K; Kaplan E; Palmer EM; van Seventer GA; Straus FH; Diaz M; Ober C; DeGroot LJ Clin Immunol Immunopathol; 1997 Dec; 85(3):253-64. PubMed ID: 9400625 [TBL] [Abstract][Full Text] [Related]
53. Alterations of Global DNA Methylation and DNA Methyltransferase Expression in T and B Lymphocytes from Patients with Newly Diagnosed Autoimmune Thyroid Diseases After Treatment: A Follow-Up Study. Guo Q; Wu D; Yu H; Bao J; Peng S; Shan Z; Guan H; Teng W Thyroid; 2018 Mar; 28(3):377-385. PubMed ID: 29336230 [TBL] [Abstract][Full Text] [Related]
54. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells. McLachlan SM; Nagayama Y; Pichurin PN; Mizutori Y; Chen CR; Misharin A; Aliesky HA; Rapoport B Endocrinology; 2007 Dec; 148(12):5724-33. PubMed ID: 17823263 [TBL] [Abstract][Full Text] [Related]
55. Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease. Izumi Y; Takeoka K; Amino N Endocr J; 2005 Aug; 52(4):493-7. PubMed ID: 16127219 [TBL] [Abstract][Full Text] [Related]
56. Clinical evaluation of biotin-binding immunoglobulin in patients with Graves' disease. Nagamine T; Takehara K; Fukui T; Mori M Clin Chim Acta; 1994 Apr; 226(1):47-54. PubMed ID: 7915219 [TBL] [Abstract][Full Text] [Related]
57. Analysis of T-cell receptor usage in activated T-cell clones from Hashimoto's thyroiditis and Graves' disease. Lipoldova M; Londei M; Grubeck-Loebenstein B; Feldmann M; Owen MJ J Autoimmun; 1989 Feb; 2(1):1-13. PubMed ID: 2473762 [TBL] [Abstract][Full Text] [Related]
58. Development of Graves' hyperthyroidism from primary hypothyroidism in a case of thyroid hemiagenesis. Bando Y; Nagai Y; Ushiogi Y; Toya D; Tanaka N; Fujisawa M Thyroid; 1999 Feb; 9(2):183-7. PubMed ID: 10090320 [TBL] [Abstract][Full Text] [Related]
59. Expression of adhesion molecules on infiltrating T cells in thyroid glands from patients with Graves' disease. Ishikawa N; Eguchi K; Ueki Y; Nakashima M; Shimada H; Ito K; Nagataki S Clin Exp Immunol; 1993 Nov; 94(2):363-70. PubMed ID: 7900942 [TBL] [Abstract][Full Text] [Related]
60. The role of T-lymphocyte subsets and interleukin-5 blood levels among Indian subjects with autoimmune thyroid disease. Gopalakrishnan S; Sen S; Adhikari JS; Chugh PK; Sekhri T; Rajan S Hormones (Athens); 2010; 9(1):76-81. PubMed ID: 20363725 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]